Firefly Neuroscience, Inc.
AIFF
$2.66
$0.0110.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 568.75% | -72.48% | -78.31% | -84.55% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 568.75% | -72.48% | -78.31% | -84.55% | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 529.69% | -72.48% | -78.31% | -84.55% | -- |
| SG&A Expenses | 151.37% | 158.34% | 158.69% | 273.15% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 136.75% | 149.35% | 159.73% | 188.47% | -- |
| Operating Income | -130.70% | -180.26% | -198.25% | -243.33% | -- |
| Income Before Tax | -455.23% | -602.18% | -302.85% | -218.05% | -- |
| Income Tax Expenses | 500.00% | 100.00% | 100.00% | -- | -- |
| Earnings from Continuing Operations | -455.24% | -602.02% | -302.77% | -218.10% | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -455.24% | -602.02% | -302.77% | -218.10% | -- |
| EBIT | -130.70% | -180.26% | -198.25% | -243.33% | -- |
| EBITDA | -203.18% | -301.55% | -163.67% | -198.48% | -- |
| EPS Basic | -215.25% | -335.75% | -194.97% | -136.69% | -- |
| Normalized Basic EPS | -156.58% | -257.46% | -175.09% | -112.71% | -- |
| EPS Diluted | -215.25% | -335.75% | -194.97% | -136.69% | -- |
| Normalized Diluted EPS | -156.58% | -257.46% | -175.09% | -112.71% | -- |
| Average Basic Shares Outstanding | 116.37% | -35.33% | -56.91% | -64.52% | -- |
| Average Diluted Shares Outstanding | 116.37% | -35.33% | -56.91% | -64.52% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |